We are monitoring the impact of COVID-19 on North America Colorectal Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 565
Share on
Share on

North America Colorectal Cancer Market Research Report – Segmented By Diagnosis, Treatment & Country (The United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 565
Pages: 137

North America Colorectal Cancer Market Size (2021 to 2026)

The size of the Colorectal Cancer Market in North America was worth USD 4.57 billion in 2021. It is estimated to be growing at a CAGR of 2.21% and worth USD 5.10 billion by 2026.

Though there has been extensive progress in science and technology to combat cancer, it continues to threaten lives across the globe. Colorectal cancer, the third most common type of cancer is fast becoming a horrible reality for many.

Colorectal cancer is a result of unrestrained cell growth that occurs in the appendix, colon, and the rectum region. Some of the normally seen symptoms of colorectal cancer are blood in the stool, weight loss, fatigue, and irregular bowel movements. Colorectal cancer is identified with a biopsy, which then followed by medical imaging to know its extent. Depending on the stage and how much cancer has expanded, a combination of radiation therapy, chemotherapy, and targeted therapy is recommended by most oncologists.

The growth of the North America Colorectal Cancer Market is mainly driven by factors such as a rise in pipeline colorectal cancer screening tests, an aging population, increasing awareness, and government policies to provide better care for Colorectal Cancer.

The high cost of screening tests is one of the main factors hindering the growth of the market.

This research report on the North America Colorectal Cancer Market has been segmented and sub-segmented into the following categories:

By Diagnosis:

  • Digital Rectal Examination
  • Faecal Occult Blood Test
  • Flexible Sigmoidoscopy
  • Colonoscopy
  • Virtual Colonoscopy

By Treatment:

  • Surgery and Radiation Therapy
  • Chemotherapy
  • Targeted Therapies
  • Resistance to Pharmacological Therapies

By Country: 

  • The United States
  • Canada
  • Rest of North America

Regionally, the USA leads the market in this region with a share of almost 85%. The North America market is very modern and is focused on innovating cost-effective techniques. Companies are committed to research, sourcing, and quality, factors that are central to the success of the industry.

Most promising companies operating in the North American Colorectal Cancer Market profiled in this report are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group and Vaccinogen BD.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Diagnosis                               

                                5.1.1 Digital Rectal Examination 

                                5.1.2 Faecal Occult Blood Test    

                                5.1.3 Flexible Sigmoidoscopy     

                                5.1.4 Colonoscopy          

                                5.1.5 Virtual Colonoscopy            

                5.2 By Treatment                            

                                5.2.1 Surgery and Radiation Therapy      

                                5.2.2 Chemotherapy      

                                5.2.3 Targeted Therapies             

                                5.2.4 Resistance to Pharmacological Therapies   

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 United States            

                                6.3 Canada         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Diagnostics                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Alere                             

                8.3 Beckman Coulter                     

                8.4 Clinical Genomics                     

                8.5 Companion Dx                          

                8.6 Hoffmann La Roche                

                8.7 Debiopharm Group                 

                8.8 Vaccinogen BD                          

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. North America Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  2. North America Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Billion)
  3. North America Digital Rectal Examination Market, By Region, From 2021 to 2026 (USD Billion)
  4. North America Faecal Occult Blood Test Market, By Region, From 2021 to 2026 (USD Billion)
  5. North America Flexible Sigmoidoscopy Market, By Region, From 2021 to 2026 (USD Billion)
  6. North America Colonoscopy Market, By Region, From 2021 to 2026 (USD Billion)
  7. North America Virtual Colonoscopy Market, By Region, From 2021 to 2026 (USD Billion)
  8. North America Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Billion)
  9. North America Surgery and Radiation Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  10. North America Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  11. North America Targeted Therapies Market, By Region, From 2021 to 2026 (USD Billion)
  12. North America Resistance to Pharmacological Therapies Market, By Region, From 2021 to 2026 (USD Billion)
  13. United States Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Billion)
  14. United States Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Billion)
  15. Canada Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Billion)
  16. Canada Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample